Navigation Links
Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
Date:12/15/2009

ionary discovery marked the beginning of Masimo's legacy as a pulse oximetry technology innovator developing and manufacturing advanced, unique equipment each year. Under Mr. Kiani's leadership, in 2005 Masimo unveiled its second ground-breaking innovation, Masimo Rainbow SET Pulse CO-Oximetry with the advanced ability to measure several blood constituents that traditionally necessitated invasive methods," Frost & Sullivan continued. "Considerable enhancements were made in this product line with the capacity to measure carboxyhemoglobin (SpCO®) in 2005, methemoglobin (SpMet®) in 2006, and pleth variability index (PVI(TM)) in 2007. The latest Rainbow innovation from Masimo launched in 2008 is the noninvasive total hemoglobin (SpHb(TM)). Additionally, this novel equipment also measures pulse rate, perfusion index, and oxyhemoglobin and plays a critical role in early detection and treatment of life-threatening conditions."

Frost & Sullivan added that the key to Mr. Kiani's success as the CEO of Masimo "lies in directing his technological inventions to strategically address the unmet needs of the market" and that under his leadership, Masimo's innovations have "redefined patient monitoring systems." The award summary goes on to cite "the strategies adopted by Mr. Kiani as the CEO of Masimo have persistently created new industry standards. The novel product portfolio of Masimo has added a new dimension to noninvasive patient monitoring equipment that has considerably facilitated early detection of challenging patient conditions."

"As a dynamic entrepreneur, he has accepted technological and business challenges successfully, resolved them, and created new industry benchmarks during this process. In this context, it is relevant to mention that in 2006, Mr. Kiani's relentless efforts enabled Masimo to attain a historic victory against Nellcor division of Tyco Healthcare in one of the biggest patent infringement violation lawsuits. Des
'/>"/>

SOURCE Masimo Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
2. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
3. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
4. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
5. Masimo to Report Third Quarter 2009 Financial Results on November 3, 2009
6. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
7. New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood
8. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
9. Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress
10. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
11. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
(Date:6/19/2013)... YORK , June 19, 2013 ... brand new infographic summary of the results from ... a third of all respondents stated that CROs would be ... 50% of respondents will be running 6 or more clinical ... with the Clinical Trial Supply USA ...
(Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... that VPII Escrow Corp., a newly formed wholly owned ... of approximately $3.2 billion aggregate principal amount of senior ... in 2021 and in 2023, with final tranching determined ... the net proceeds from the offering, together with proceeds ...
Breaking Medicine Technology:Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
(Date:6/19/2013)... AquaPrint Solutions in Thomson, IL is proud to ... newly-designed Harley Davidson motorcycle gas tank. A couple of weeks ... idea of taking a split tank motorcycle that had been ... into a work of art. , In October of ... seats that had been dipped in a water transfer printer ...
(Date:6/19/2013)... 2013 Ethigen announced today the US ... service , providing next-generation sequencing (NGS) and rearrangement analysis ... part of an expanded hereditary cancer panel, including full ... links to cancer risk: MLH1, MSH2, MSH6, APC, MUTYH ... FH, FLCN, PDGFRA, and KIT. , The expanded ...
(Date:6/19/2013)... When looking for ways to lose weight ... how to lose belly fat and excess fat in other ... Unnecessary and excess fat storage in these areas can be ... created their hCG diets to specially address these ... loss aids with nutritious meal plans and education on healthy ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Walkingspree, a ... today announced the launch of its new Facebook App. ... motivate and inspire participants to reach their program fitness ... platform , Walkingspree clients are given more tools to ... member profile. , Corporate clients may choose whether or ...
(Date:6/19/2013)... The website HealthNewsWires.com has recently published an informative article ... tips to manage and prevent the condition. , In ... defines insulin resistance as a condition that ... from the bloodstream. Glucose, or blood sugar, is ... systems of the body for normal function. The ...
Breaking Medicine News(10 mins):Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce A New Four Phase Program that Allows Patients to Lose Belly Fat, Thigh Fat and Underarm Fat Easily 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:Effects of Insulin Resistance and How to Increase Insulin Sensitivity Published in New Video by Health News Wire 2
... highlighted that patients who receive a hematopoietic stem cell transplant ... especially// if they are older during the time of the ... ,A peer-reviewed journal of the American Cancer ... allogeneic HSCT, the comparative risk of a second cancer is ...
... British government has been investing millions of pounds into ... to conduct a massive survey to determine how// accessible ... the intended survey, patients are going to be endowed ... contributing to the doctor’s income. ,The Prime Minister ...
... has planned to kill cats and dogs over fears of ... cull even dogs and cats so as to prevent further ... deadly H5N1 virus at a chicken farm last week. Animal ... extreme measure' because there was no scientific evidence that cats ...
... According to a new study published in January ... short-term structural changes in the cognitive areas of ... journal of the American Cancer Society, the researchers ... months of receiving adjuvant chemotherapy, significant regions of ...
... have observed an alarming trend in the kids, even those between ... teenagers. The physical and// behavioral changes which marks the teenage years ... of 8 to 12; so the sobriquet ‘tweens’, seems to fit ... fancy to own expensive items like cell phones and iPods. The ...
... in Australia to study the attitudes of people towards “tissue ... concerned about the// outcome of storage of tissue samples at ... found that ,most people were wary about biopsy tissue being ... possibly be used to produce human clones in the future. ...
Cached Medicine News:Health News:Stem cell transplant recipients face significant risk of second cancer 2Health News:Britons soon will practise telling GPs how to practice 2Health News:Banking (T)issues : cloning issue surfaces 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: